WithdrawnNot Applicable

Treating Heart Failure With Enhanced External Counterpulsation (EECP)

Germany0Started 2017-01

Plain-language summary

Enhanced external counterpulsation (EECP) is an outpatient coronary artery disease (CAD) therapy that involves the cyclical inflation/deflation of cuffs wrapped around the lower extremities. However, the possible benefits of EECP in patients with heart failure (HF) (New York Heart Association \[NYHA\] classes II to IV) and cardiomyopathy are unclear.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. with optimal medical therapy
✓. caused by ischemic or non-ischemic cardiomyopathy

What they're measuring

Systolic and diastolic heart function

Timeframe: A period of 1 year

Trial details

NCT IDNCT03021213

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-06

View on ClinicalTrials.gov More Heart Failure trials